179 related articles for article (PubMed ID: 35476232)
61. Inhibitor of BRAF
Smirnova SY; Al-Radi LS; Moiseeva TN; Gemdzhian EG; Yakutik IA; Julhakyan HL; Novikov VA; Galstyan GM; Sudarikov AB
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):427-430. PubMed ID: 33811006
[TBL] [Abstract][Full Text] [Related]
62. Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAF V600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays.
Brown NA; Weigelin HC; Bailey N; Laliberte J; Elenitoba-Johnson KS; Lim MS; Betz BL
Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):590-600. PubMed ID: 24503706
[TBL] [Abstract][Full Text] [Related]
63. Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center.
Watts JM; Kishtagari A; Hsu M; Lacouture ME; Postow MA; Park JH; Stein EM; Teruya-Feldstein J; Abdel-Wahab O; Devlin SM; Tallman MS
Br J Haematol; 2015 Oct; 171(1):84-90. PubMed ID: 26115047
[TBL] [Abstract][Full Text] [Related]
64. Hairy cell leukemia has a B-cell genotype.
Meyers FJ; Cardiff RD; Taylor CR; Zuniga M; Radich J
Hematol Oncol; 1984; 2(2):145-50. PubMed ID: 6430776
[TBL] [Abstract][Full Text] [Related]
65. Polyclonal B-cell lymphocytosis with features resembling hairy cell leukemia-Japanese variant.
Machii T; Yamaguchi M; Inoue R; Tokumine Y; Kuratsune H; Nagai H; Fukuda S; Furuyama K; Yamada O; Yahata Y; Kitani T
Blood; 1997 Mar; 89(6):2008-14. PubMed ID: 9058722
[TBL] [Abstract][Full Text] [Related]
66. The importance of the tissue microenvironment in hairy cell leukemia.
Sivina M; Burger JA
Best Pract Res Clin Haematol; 2015 Dec; 28(4):208-16. PubMed ID: 26614899
[TBL] [Abstract][Full Text] [Related]
67. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Cornet E
Am J Hematol; 2017 Dec; 92(12):1382-1390. PubMed ID: 29110361
[TBL] [Abstract][Full Text] [Related]
68. Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
Hsieh YC; Chang ST; Chuang SS; Lu CL; Tsao CJ; Lin CN; Li CY
Int J Clin Exp Pathol; 2011 Jan; 4(2):183-9. PubMed ID: 21326814
[TBL] [Abstract][Full Text] [Related]
69. Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia.
Tiacci E; Pucciarini A; Bigerna B; Pettirossi V; Strozzini F; Martelli MP; Tabarrini A; Drexler HG; Falini B
Blood; 2012 May; 119(22):5332-3. PubMed ID: 22653958
[No Abstract] [Full Text] [Related]
70. A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?
Schlick K; Troch M; Placher-Sorko G; Faber V; Neureiter D; Berghoff AS; Preusser M; Greil R; Hopfinger G
Ann Hematol; 2015 Feb; 94(2):345-6. PubMed ID: 25055797
[No Abstract] [Full Text] [Related]
71. A comparison of high resolution melting, allele-specific priming and Sanger sequencing for the detection of BRAFV600E mutation in hairy cell leukaemia from different haematological specimens.
So CC; Chan A; Chung LP; Siu L; Wong WS; Wong KF
Pathology; 2014 Oct; 46(6):533-7. PubMed ID: 25158814
[TBL] [Abstract][Full Text] [Related]
72. Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias.
Tschernitz S; Flossbach L; Bonengel M; Roth S; Rosenwald A; Geissinger E
Br J Haematol; 2014 May; 165(4):529-33. PubMed ID: 24433452
[TBL] [Abstract][Full Text] [Related]
73. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.
Matutes E; Morilla R; Owusu-Ankomah K; Houliham A; Meeus P; Catovsky D
Leuk Lymphoma; 1994; 14 Suppl 1():57-61. PubMed ID: 7820054
[TBL] [Abstract][Full Text] [Related]
74. Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.
Blombery PA; Wong SQ; Hewitt CA; Dobrovic A; Maxwell EL; Juneja S; Grigoriadis G; Westerman DA
Haematologica; 2012 May; 97(5):780-3. PubMed ID: 22133769
[TBL] [Abstract][Full Text] [Related]
75. Immunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia.
Wang XJ; Kim A; Li S
Int J Clin Exp Pathol; 2014; 7(7):4323-8. PubMed ID: 25120816
[TBL] [Abstract][Full Text] [Related]
76. Vemurafenib for relapsed or refractory hairy-cell leukaemia.
Baker H
Lancet Oncol; 2015 Oct; 16(13):e484. PubMed ID: 26387749
[No Abstract] [Full Text] [Related]
77. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
78. Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation.
Peyrade F; Re D; Ginet C; Gastaud L; Allegra M; Ballotti R; Thyss A; Zenz T; Auberger P; Robert G
Haematologica; 2013 Feb; 98(2):e20-2. PubMed ID: 23300174
[No Abstract] [Full Text] [Related]
79. Hairy Cell Leukemia with Systemic Lymphadenopathy: Detection of BRAF Mutations in Both Lymph Node and Peripheral Blood Specimens.
Okada K; Kunitomi A; Sakai K; Muranushi H; Okamoto Y; Tsukamoto T; Sugiura H; Matsui H; Jo T; Ueda T; Onishi T; Ide M; Kimura S; Notohara K; Ueda Y
Intern Med; 2015; 54(11):1397-402. PubMed ID: 26027995
[TBL] [Abstract][Full Text] [Related]
80. [Detection of BRAF V600E mutation in hairy cell leukemia by high- resolution melting analysis].
Zhang Y; Liu H; Qi J; Liu W; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):207-9. PubMed ID: 24666485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
